跳至主要内容
临床试验/ITMCTR2100004820
ITMCTR2100004820招募中4 期

Real world study on the efficacy and safety of Shenqi Jiangtang tablets in the treatment of type 2 diabetes mellitus

People's Hospital of Wuhan University0 个研究点开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • 1. Patients who met the diagnostic criteria of Chinese guidelines for the prevention and treatment of type 2 diabetes (2017 Edition);
  • 2. Aged 18-75 years;
  • 3. 7% < HbA1c <= 10%;
  • 4. Patients agreed and signed informed consent.

排除标准

  • 1. Blood glucose >= 13.57mmol/l;
  • 2. Abnormal liver and kidney function: ALT or ast > 2 x ULN or TBIL > 2 x ULN; Cr > 1 x ULN or CCR < 60ml / min;
  • 3. Pregnant or lactating women within half a year;
  • 4. Allergic constitution or known allergy to the drugs and their components used in this test;
  • 5. Patients considered unsuitable by the researchers.

研究者

发起方
People's Hospital of Wuhan University

相似试验